Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Medtronic doc hire: Martin Rothman will join the company Jan. 4 as VP of medical affairs for Medtronic's Santa Clara, Calif., coronary and peripheral vascular business. Rothman is an interventional cardiologist from the United Kingdom, where he spent 27 years at the London Chest Hospital

You may also be interested in...



People In Brief

Biotronik CRM: Veteran Medtronic cardiac rhythm management unit executive Patrick L. Horan joins Biotronik May 14 as VP of corporate sales for U.S. operations, where he will help drive sales for implantable cardioverter defibrillators and pacemakers. The Berlin-based cardiovascular device company has increased efforts in the past several years to push into the U.S. CRM market, still dominated by Medtronic, Boston Scientific and St. Jude Medical. Horan left Medtronic last year and briefly went to surgical device firm Synovis Life Technologies before joining Biotronik. Horan has also been active in the group purchasing organization community as a board member of the Health Industry Group Purchasing Association (1"The Gray Sheet" Dec. 14, 2009)

Coronavirus Demanding Focus Of US FDA’s Antiviral, Other Divisions

Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.

Topics

UsernamePublicRestriction

Register

MT028279

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel